Linhai Silu Glasses Co., Ltd. – Trademark Portfolio

Entity Type: 99

Linhai Silu Glasses Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MIUIKI and SILUHENG. The owner is based in Taizhou, Zhejiang.

4/F,Aoguang Optics Electronics Co., Ltd

Xinxing Road, Duqiao Town, Linhai

Taizhou, Zhejiang 318000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MIUIKI
MIUIKI
Registered 2020
SILUHENG
SILUHENG
Registered 2020

Trademark Classifications

Linhai Silu Glasses Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Linhai Silu Glasses Co., Ltd. have?

Linhai Silu Glasses Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Linhai Silu Glasses Co., Ltd. file in?

Linhai Silu Glasses Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Linhai Silu Glasses Co., Ltd.'s most well-known trademarks?

Linhai Silu Glasses Co., Ltd.'s registered trademark portfolio includes well-known marks such as MIUIKI and SILUHENG. These are among 2 currently registered trademarks in the portfolio.

What is Linhai Silu Glasses Co., Ltd.'s trademark registration success rate?

Linhai Silu Glasses Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.